Drugs / EVP-0962
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01661673 | Nov 2012 → Oct 2013 | Alzheimer disease, cognitive impairment with or without cerebellar ataxia | FORUM Pharmaceuticals Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVP-0962 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01661673 ↗ |
| Route | Oral | “Orally administered once daily for 14 days” NCT01661673 ↗ |